Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

2 Jul 2014 18:02

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the “Company”) was informed yesterday that Matthew Wineinger, a Person Discharging Managerial Responsibilities, disposed of a total of 52,228 ordinary 25p shares in the capital of the Company (“Shares”) on 1 July 2014 in the United States.

51,458 Shares were sold at a price of 665.89 pence per Share (being the equivalent of US$11.43 per Share using an exchange rate of 1.7165) and 770 Shares were sold at a price of 673.46 pence per Share (being the equivalent of US$11.56 per Share using an exchange rate of 1.7165).

Mr Wineinger has already met the requirements of the Company’s Executive Shareholding Policy.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

2 July 2014

Copyright Business Wire 2014

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.